Denali Therapeutics
DNLI
DNLI
249 hedge funds and large institutions have $2.5B invested in Denali Therapeutics in 2025 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 86 increasing their positions, 71 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
10.38% more ownership
Funds ownership: 92.67% → 103.06% (+10%)
4% more funds holding
Funds holding: 240 → 249 (+9)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
249
Holding in Top 10
3
Calls
$2.13M
Puts
$537K
Top Buyers
| 1 | +$28.2M | |
| 2 | +$28M | |
| 3 | +$27.3M | |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
+$24.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18M |
Top Sellers
| 1 | -$22.2M | |
| 2 | -$17.4M | |
| 3 | -$15.8M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$13.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11M |